Lavens S E, Proud D, Warner J A
Department of Physiology and Pharmacology, University of Southampton, Bassett Crescent East, UK.
J Immunol Methods. 1993 Nov 5;166(1):93-102. doi: 10.1016/0022-1759(93)90332-2.
Studies of human lung mast cells have usually focused on histamine release, although the enzymes stored in the granules may also contribute to the pathophysiology of the allergic response. We have used a simple colorimetric assay for tryptase to follow the release of proteolytic enzymes from human lung mast cells in vitro. Either human lung mast cell supernatants or authentic mast cell tryptase were mixed with benzoyl-DL-arginine-p-nitroaniline and incubated for up to 72 h at 37 degrees C. The appearance of nitroaniline was then measured at 410 nm in an ELISA plate reader. Cells were sonicated in H2O to measure total tryptase and histamine. Human lung mast cells contained the equivalent of 11.2 +/- 0.7 pg tryptase per cell and 3.2 +/- 0.3 pg of histamine. The amount of tryptase measured colorimetrically correlated with the level of tryptase measured by radioimmunoassay (Pharmacia), r = 0.92, P < 0.01. The inhibition profile of the proteolytic enzyme measured by the cleavage of BAPNA, was found to be identical to that of authentic lung mast cell tryptase. Over 90% of the maximum tryptase release was complete within 15 min whilst histamine release occurred within 5 min. In cells stimulated with 10 micrograms/ml anti-IgE we found a strong correlation between the release of tryptase and histamine, r = 0.95, P < 0.005. Finally, investigations with various pharmacological agents have supported our initial hypothesis that tryptase would mimic histamine release and provide an alternative marker for mast cell activation. In summary, we have utilised a simple enzymic assay as an indicator of human lung mast cell degranulation. In washed lung mast cells this assay appears be specific for granule tryptase and release of this activity into the supernatants of challenged cells correlates well with the presence of histamine. This assay offers several advantages over current methods of measuring mediator release from human lung mast cells in vitro and should provide an inexpensive and sensitive technique for following mast cell degranulation.
对人肺肥大细胞的研究通常集中在组胺释放上,尽管储存在颗粒中的酶也可能在过敏反应的病理生理学中起作用。我们使用了一种简单的比色法来检测类胰蛋白酶,以追踪人肺肥大细胞在体外蛋白水解酶的释放情况。将人肺肥大细胞上清液或纯肥大细胞类胰蛋白酶与苯甲酰-DL-精氨酸-对硝基苯胺混合,并在37℃下孵育长达72小时。然后在酶联免疫吸附测定(ELISA)酶标仪上于410nm处测量硝基苯胺的出现情况。将细胞在水中超声处理以测量总类胰蛋白酶和组胺。人肺肥大细胞每个细胞含有相当于11.2±0.7pg的类胰蛋白酶和3.2±0.3pg的组胺。比色法测量的类胰蛋白酶量与放射免疫测定法(Pharmacia)测量的类胰蛋白酶水平相关,r = 0.92,P <0.01。通过BAPNA裂解测量的蛋白水解酶的抑制谱与纯肺肥大细胞类胰蛋白酶的抑制谱相同。超过90%的最大类胰蛋白酶释放在15分钟内完成,而组胺释放在5分钟内发生。在用10微克/毫升抗IgE刺激的细胞中,我们发现类胰蛋白酶和组胺的释放之间有很强的相关性,r = 0.95,P <0.005。最后,用各种药理试剂进行的研究支持了我们最初的假设,即类胰蛋白酶会模拟组胺释放,并为肥大细胞活化提供另一种标志物。总之,我们利用了一种简单的酶测定法作为人肺肥大细胞脱颗粒的指标。在洗涤过的肺肥大细胞中,该测定法似乎对颗粒类胰蛋白酶具有特异性,并且这种活性释放到受刺激细胞的上清液中与组胺的存在密切相关。该测定法比目前体外测量人肺肥大细胞介质释放的方法具有几个优点,并且应该为追踪肥大细胞脱颗粒提供一种廉价且灵敏的技术。